Devon Gubbins, O.D.
NPI 1861808149 · Optometrist · Minneapolis, MN
Enrolled with Medicare as Practitioner - Optometry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1861808149
- Entity type
- Individual
- Primary specialty
- OptometristEye and Vision Services Providers
- Credential
- O.D.
- Sex
- Female
- Sole proprietor
- No
- License
- 3391 (MN)
Specialties & taxonomies
Eye and Vision Services Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
11 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
464 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Complete Exam of Visual System92014 | 278 | $124 |
| New Patient Complete Exam of Visual System92004 | 57 | $147 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 48 | $87 |
| Imaging of Optic Nerve92133 | 34 | $33 |
| Exam of Visual Field With Extended Testing92083 | 31 | $63 |
| Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More99212 | 16 | $55 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 10 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Latanoprost | 199 | 59 |
| Timolol Maleate | 68 | 21 |
| Cyclosporinebrand: Restasis | 44 | 16 |
| Brimonidine Tartrate | 20 | — |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 18 | — |
| Lifitegrastbrand: Xiidra | 15 | — |
| Doxycycline Monohydrate | 15 | — |
Practice location
Mailing address
Registry dates
- Enumerated
- 2014-07-07
- Last updated
- 2014-07-07
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.